Merck News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Orderbuch			Analysen
Historisch

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Orderbuch

Analysen

Historisch

22.09.22	AstraZeneca Announces Approval Of Lynparza In China (RTTNews)
20.09.22	Merck To Begin Phase 3 Program With Lower Dose Of Islatravir With Doravirine (RTTNews)
13.09.22	Merck: KEYTRUDA Approved In Canada For Adjuvant Treatment Of Patients With Stage IIB Or IIC Melanoma (RTTNews)
12.09.22	Seagen, Astellas, Merck: EV-103 Results Support Investigation Of Enfortumab Vedotin, Pembrolizumab (RTTNews)
12.09.22	Astellas, Seagen and Merck Announce Results of Clinical Trial Investigating PADCEV® (enfortumab vedotin-ejfv) with KEYTRUDA® (pembrolizumab) and PADCEV as Monotherapy in First-Line Advanced Urothe... (PR Newswire)
09.09.22	AstraZeneca Says LYNPARZA Combination Shows Meaningful OS In Ovarian Cancer Across Phase III Trials (RTTNews)
25.08.22	AstraZeneca Reports Approval Of Tagrisso, Ultomiris & Lynparza In Japan (RTTNews)
23.08.22	Merck & Co Gets Fast Track Status For Investigational Anticoagulant Therapy MK-2060 (RTTNews)
19.08.22	Statement of changes in beneficial ownership of securities (RSS)
16.08.22	Merck And Orna In Deal To Develop Vaccines And Treatments For Infectious Diseases, Cancer (RTTNews)
16.08.22	AstraZeneca: FDA Grants Priority Review To SNDA For Lynparza With Abiraterone For MCRPC (RTTNews)
11.08.22	Roche Announces FDA Approval Of Label Expansion For VENTANA MMR RxDx Panel (RTTNews)
03.08.22	Merck : Phase 3 Trial Of Keytruda Combination In Liver Cancer Fails To Meet Main Goal (RTTNews)
28.07.22	Merck Updates FY22 Guidance (RTTNews)
26.07.22	Astellas, Seagen Report Positive Topline Results For Padcev With Keytruda To Treat Urothelial Cancer (RTTNews)
26.07.22	Initial statement of beneficial ownership of securities (RSS)
20.07.22	Merck: Phase 3 KEYNOTE-412 Trial With KEYTRUDA Fails To Meet Primary Endpoint (RTTNews)
13.07.22	Merck, Orion In Deal To Develop Orion's Prostate Cancer Drug ODM-208 (RTTNews)
08.07.22	Initial statement of beneficial ownership of securities (RSS)
07.07.22	Merck Reportedly In Advanced Talks To Buy Seagen (RTTNews)
27.06.22	AstraZeneca : Lynparza Recommended For Approval In EU For High-risk Early Breast Cancer (RTTNews)
24.06.22	Merck: EU Approves KEYTRUDA For Patients Above 12 Years In Stage IIB, IIC And III Melanoma (RTTNews)
22.06.22	FDA Approves Merck's Vaxneuvance For Prevention Of Invasive Pneumococcal Disease In Children (RTTNews)
21.06.22	Merck Presents Positive Results From Phase 1/2 Study Of Pneumococcal Conjugate Vaccine (RTTNews)
01.06.22	Initial statement of beneficial ownership of securities (RSS)
24.05.22	EU Approves Merck's Keytruda Combination For Early-stage Triple-negative Breast Cancer (RTTNews)
28.04.22	Merck Raises, Narrows Full-year Guidance (RTTNews)
18.04.22	Merck's Keytruda Scores Another Regulatory Nod In Canada (RTTNews)
14.04.22	Merck's 21-valent Pneumococcal Conjugate Vaccine Gets FDA Breakthrough Therapy Designation (RTTNews)
11.04.22	Merck: GARDASIL 9 Approved In Canada To Prevent Oropharyngeal And Other Head And Neck Cancers (RTTNews)
01.04.22	Merck, Ridgeback: COVID Antiviral LAGEVRIO Clears Infectious SARS-CoV-2 Faster Than Placebo (RTTNews)
01.04.22	Merck: FDA Extends PDUFA Date Of SBLA For VAXNEUVANCE - Quick Facts (RTTNews)
01.04.22	Form 4 310158 (RSS)
28.03.22	Biotech Stocks Facing FDA Decision In April 2022 (RTTNews)
25.03.22	Bristol Myers Squibb: FDA Extends PDUFA Goal Date For Reblozy By Three Months For Full Review (RTTNews)
15.03.22	Merck Stoping Phase 3 KEYLYNK-010 Trial Investigating KEYTRUDA In Combination With LYNPARZA (RTTNews)
15.03.22	Imugene, Merck To Evaluate HER-Vaxx - KEYTRUDA Combination In Phase 2 Trial For Gastric Cancer (RTTNews)
04.03.22	Genome, Merck To Evaluate GEN-001 - KEYTRUDA Combination In Phase 2 Trial In Biliary Tract Cancer (RTTNews)
28.02.22	Biotech Stocks Facing FDA Decision In March 2022 (RTTNews)
28.02.22	Form 4 310158 (RSS)
15.02.22	AstraZeneca: Lynparza Plus Abiraterone In Phase III Trial Show Positive Results In MCRPC Patients (RTTNews)
11.02.22	Form 4 310158 (RSS)
03.02.22	Merck Q4 Profit Beats Estimates (RTTNews)
28.01.22	Merck: Molnupiravir Shows Consistent Antiviral Activity Against Omicron In Multiple In Vitro Studies (RTTNews)
27.01.22	EU Approves Merck's KEYTRUDA As Adjuvant Therapy For Renal Cell Carcinoma (RTTNews)
24.01.22	FDA Refuses To Approve Merck's 'gefapixant' To Treat Chronic Cough (RTTNews)
18.01.22	Merck Animal Health's Third Veterinarian Wellbeing Study Reveals Increased Health Challenges and Psychological Distress Among Veterinarians (PR Newswire)
18.01.22	Merck, Ridgeback In Supply Agreement With UNICEF For 'molnupiravir' To Treat Covid (RTTNews)
10.01.22	Gilead Announces Clinical Trial Collaborations With Merck - Quick Facts (RTTNews)
04.01.22	Form 4 310158 (RSS)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Logitech Intl	73.52	1.69 %	K V
ABB	51.66	0.78 %	K V
Sonova Hldg	299.90	0.74 %	K V
Alcon	77.62	0.65 %	K V
Sika	237.00	0.51 %	K V
Swiss Life Hldg	686.20	-0.61 %	K V
Zurich Insur Gr	557.20	-0.64 %	K V
Kuehne+Nagel Int	211.80	-0.75 %	K V
Givaudan	3’866.00	-1.07 %	K V
Novartis	91.44	-1.70 %	K V

mehr

09:28		Optimismus in Europa: STOXX 50 zum Start im Aufwind
09:28		LSE-Handel FTSE 100 startet im Minus
09:28		Mittwochshandel in Frankfurt: LUS-DAX beginnt Sitzung mit Gewinnen
09:28		STOXX-Handel: Euro STOXX 50 zum Start auf grünem Terrain
09:28		SPI-Handel aktuell: SPI startet in der Verlustzone

09:28

Optimismus in Europa: STOXX 50 zum Start im Aufwind

09:28

LSE-Handel FTSE 100 startet im Minus

09:28

Mittwochshandel in Frankfurt: LUS-DAX beginnt Sitzung mit Gewinnen

09:28

STOXX-Handel: Euro STOXX 50 zum Start auf grünem Terrain

09:28

SPI-Handel aktuell: SPI startet in der Verlustzone